These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33530435)

  • 1. Hepatic and Extrahepatic Colorectal Metastases Have Discordant Responses to Systemic Therapy. Pathology Data from Patients Undergoing Simultaneous Resection of Multiple Tumor Sites.
    Vigano L; Corleone P; Darwish SS; Turri N; Famularo S; Viggiani L; Rimassa L; Del Fabbro D; Di Tommaso L; Torzilli G
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33530435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival.
    Viganò L; Capussotti L; De Rosa G; De Saussure WO; Mentha G; Rubbia-Brandt L
    Ann Surg; 2013 Nov; 258(5):731-40; discussion 741-2. PubMed ID: 24045448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OncoSurge: a strategy for long-term survival in metastatic colorectal cancer.
    Alberts S; Poston G
    Colorectal Dis; 2003 Nov; 5 Suppl 3():20-8. PubMed ID: 23573557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes.
    Sahajpal A; Vollmer CM; Dixon E; Chan EK; Wei A; Cattral MS; Taylor BR; Grant DR; Greig PD; Gallinger S
    J Surg Oncol; 2007 Jan; 95(1):22-7. PubMed ID: 17066435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer.
    Nakayama I; Suenaga M; Wakatsuki T; Ichimura T; Ozaka M; Takahari D; Shinozaki E; Chin K; Ueno M; Mizunuma N; Yamaguchi T
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):133-9. PubMed ID: 25994854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection of Concomitant Hepatic and Extrahepatic Metastases from Colorectal Cancer - A Worthwhile Operation?
    Diaconescu A; Alexandrescu S; Ionel Z; Zlate C; Grigorie R; Brasoveanu V; Hrehoret D; Ciurea S; Botea F; Tomescu D; Droc G; Croitoru A; Herlea V; Boros M; Grasu M; Dumitru R; Toma M; Ionescu M; Vasilescu C; Popescu I
    Chirurgia (Bucur); 2017; 112(6):673-682. PubMed ID: 29288609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases.
    Wang Y; Yuan YF; Lin HC; Li BK; Wang FH; Wang ZQ; Ding PR; Chen G; Wu XJ; Lu ZH; Pan ZZ; Wan DS; Sun P; Yan SM; Xu RH; Li YH
    Chin J Cancer; 2017 Oct; 36(1):78. PubMed ID: 28969708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Mathematical Model to Estimate Chemotherapy Concentration at the Tumor-Site and Predict Therapy Response in Colorectal Cancer Patients with Liver Metastases.
    Anaya DA; Dogra P; Wang Z; Haider M; Ehab J; Jeong DK; Ghayouri M; Lauwers GY; Thomas K; Kim R; Butner JD; Nizzero S; Ramírez JR; Plodinec M; Sidman RL; Cavenee WK; Pasqualini R; Arap W; Fleming JB; Cristini V
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33503971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic resection for colorectal liver metastases.
    Roh MS
    Hematol Oncol Clin North Am; 1989 Mar; 3(1):171-81. PubMed ID: 2645270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics of fluorouracil, irinotecan, and oxaliplatin in hepatic metastases of colorectal cancer: clinical implications.
    Lentz F; Tran A; Rey E; Pons G; Tréluyer JM
    Am J Pharmacogenomics; 2005; 5(1):21-33. PubMed ID: 15727486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection.
    Nagashima I; Takada T; Matsuda K; Adachi M; Nagawa H; Muto T; Okinaga K
    J Hepatobiliary Pancreat Surg; 2004; 11(2):79-83. PubMed ID: 15127268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer.
    Kim JC; Kim HC; Lee KH; Yu CS; Kim TW; Chang HM; Ryu MH; Kim JH; Ha HK; Lee MG
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1026-35. PubMed ID: 16724990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis.
    Martin RC; Scoggins CR; Schreeder M; Rilling WS; Laing CJ; Tatum CM; Kelly LR; Garcia-Monaco RD; Sharma VR; Crocenzi TS; Strasberg SM
    Cancer; 2015 Oct; 121(20):3649-58. PubMed ID: 26149602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease.
    Jarnagin WR; Fong Y; Ky A; Schwartz LH; Paty PB; Cohen AM; Blumgart LH
    J Am Coll Surg; 1999 Jan; 188(1):33-42. PubMed ID: 9915240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.
    Lévi FA; Boige V; Hebbar M; Smith D; Lepère C; Focan C; Karaboué A; Guimbaud R; Carvalho C; Tumolo S; Innominato P; Ajavon Y; Truant S; Castaing D; De Baere T; Kunstlinger F; Bouchahda M; Afshar M; Rougier P; Adam R; Ducreux M;
    Ann Oncol; 2016 Feb; 27(2):267-74. PubMed ID: 26578731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
    Bhutiani N; Akinwande O; Martin RC
    World J Surg; 2016 May; 40(5):1178-90. PubMed ID: 26711640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes.
    Gervaz P; Rubbia-Brandt L; Andres A; Majno P; Roth A; Morel P; Mentha G
    Ann Surg Oncol; 2010 Oct; 17(10):2714-9. PubMed ID: 20405223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological response of colorectal liver metastases treated after induction treatment.
    Ben Slama S; Bacha D; Sassi A; Khadhar A; Bayar R; Bouraoui S; Lahmar A
    Tunis Med; 2017 Oct; 95(10):854-858. PubMed ID: 29873054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination chemotherapy with hepatic arterial infusion of 5-fluorouracil (5-FU) and systemic irinotecan (CPT-11) in patients with unresectable liver metastases from colorectal cancer].
    Shitara K; Munakata M; Kudo T; Kasai M; Muto O; Okada R; Mitobe S; Ishiguro A; Sakuraba H; Ikami I; Sakata Y
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2033-7. PubMed ID: 17197748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative determinants of unresectability for patients with colorectal hepatic metastases.
    Gibbs JF; Weber TK; Rodriguez-Bigas MA; Driscoll DL; Petrelli NJ
    Cancer; 1998 Apr; 82(7):1244-9. PubMed ID: 9529015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.